These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 4055696)

  • 1. Intracavitary rifampicin.
    Purohit SD; Gupta PR; Koolwal S; Jain BL; Mehta YR
    J Assoc Physicians India; 1985 Aug; 33(8):556. PubMed ID: 4055696
    [No Abstract]   [Full Text] [Related]  

  • 2. Intracavitary instillation of rifampicin.
    Purohit SD; Gupta PR; Sarkar SK; Sisodia RS; Garg AK
    J Assoc Physicians India; 1982 Jul; 30(7):480. PubMed ID: 7169479
    [No Abstract]   [Full Text] [Related]  

  • 3. [A controlled comparison of daily and intermittent administration of rifampicin in retreatment of pulmonary tuberculosis].
    Yamamoto K; Aizawa H; Sasaoka M; Kawamori Y; Kakuno J
    Kekkaku; 1972 Dec; 47(12):467-73. PubMed ID: 4652425
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experience with endobronchial and local use of rifampicin in tuberculosis].
    Abdurashitova MV; Stoianovskiĭ EA; Fok AIa
    Probl Tuberk; 1976 Jan; (l):35-8. PubMed ID: 995905
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparison of therapeutic effects of rifampicin 450 mg daily and 600 mg three times weekly on the previously treated pulmonary tuberculosis patients].
    Yamamoto M; Mizutani A; Nakamura H; Hirose H; Nagata A
    Kekkaku; 1973 May; 48(5):197-202. PubMed ID: 4732658
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapeutic effect of rifampicin on re-treatment cases of pulmonary tuberculosis. The second study: a study on the combined therapy of rifampicin with ethambutol and pyrazinamide, especially on intermittent therapy].
    Kekkaku; 1972 Dec; 47(12):457-66. PubMed ID: 4652424
    [No Abstract]   [Full Text] [Related]  

  • 7. [Early results of treatment of patients with chronic pulmonary tuberculosis with rifampicin].
    Böszörmenyi M
    Gruzlica; 1974 May; 42(5):407-10. PubMed ID: 4464228
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical study on rifampicin applied every other day for severe cavitary pulmonary tuberculosis (author's transl)].
    Kitatani F; Fujimoto S; Asahi T; Konishiike J; Sera Y
    Kekkaku; 1974 May; 49(5):133-8. PubMed ID: 4408937
    [No Abstract]   [Full Text] [Related]  

  • 9. Ambulatory intermittent rifampicin and ethambutol in the retreatment of pulmonary tuberculosis.
    Sriyabhaya N; Jittinandana A; Kecharanantana P
    J Med Assoc Thai; 1974 Nov; 57(11):551-7. PubMed ID: 4452812
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of pulmonary tuberculosis of native Black Africans a chemotherapeutic regime including rifampicin (apropos of 75 patients)].
    Ayad M; Hane A; Kane PA
    Dakar Med; 1980; 25(1):65-74. PubMed ID: 7460740
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical effects of rifampicin applied every other day for severe cavitary pulmonary tuberculosis].
    Hashimoto T; Takahashi S; Kasai K; Tamura M; Yamada M
    Kekkaku; 1972 Aug; 47(8):273-7. PubMed ID: 4660855
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of rifampicin in venous perfusion in a group of patients with pulmonary tuberculosis].
    Bettini L; Fossati C
    Clin Ter; 1976 Nov; 79(3):263-72. PubMed ID: 1017171
    [No Abstract]   [Full Text] [Related]  

  • 13. [Bacteriological relapse among the previously treated advanced pulmonary tuberculosis patients whose sputum converted to negative by the rifampicin treatment, with special reference to the duration of rifampicin administration (author's transl)].
    Yamamoto M; Morishita M; Hirano Y; Nagata A; Yazaki M
    Kekkaku; 1974 Jul; 49(7):195-9. PubMed ID: 4214961
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical effect of rifampicin-ethambutol isoniazid on untreated pulmonary tuberculosis.
    Konno K; Oizumi K; Yamada S; Ogata K; Sato M
    Sci Rep Res Inst Tohoku Univ Med; 1972 Sep; 19(2):68-72. PubMed ID: 4649624
    [No Abstract]   [Full Text] [Related]  

  • 15. A triple regimen of streptomycin, isoniazid and ethambutol or rifampicin, isoniazid and ethambutol in untreated cases of pulmonary tuberculosis. 3.
    Oka S; Sasaki M; Kobayashi T; Matsuda T
    Sci Rep Res Inst Tohoku Univ Med; 1972 Sep; 19(2):84-8. PubMed ID: 4649627
    [No Abstract]   [Full Text] [Related]  

  • 16. [Long-term results of treatment with rifampicin and ethambutol in hyperchronic pulmonary tuberculosis with polyresistant bacilli].
    Anastasatu C; Sibila S
    Ftiziologia; 1973; 22(5):477-84. PubMed ID: 4751363
    [No Abstract]   [Full Text] [Related]  

  • 17. [A comparative study on clinical efficacy of rifampicin (RFP), ethambutol (EB) and ethionamide (1321 TH) in retreatment of pulmonary tuberculosis. Report of the 13th series study part B].
    Kekkaku; 1972 May; 47(5):139-44. PubMed ID: 5042532
    [No Abstract]   [Full Text] [Related]  

  • 18. [Rifampicin in the treatment of lung and kidney tuberculosis].
    Kraan JK; Mulder RJ; Mulder-De Jong MT; van Dijk B
    Ned Tijdschr Geneeskd; 1972 Jan; 116(1):9-15. PubMed ID: 4555064
    [No Abstract]   [Full Text] [Related]  

  • 19. Trial of rifampicin in the treatment of pulmonary tuberculosis. A preliminary report.
    Sriyabhaya N; Jarumilin A
    J Med Assoc Thai; 1971 May; 54(5):304-11. PubMed ID: 5580059
    [No Abstract]   [Full Text] [Related]  

  • 20. [Results of treatment of chronically infectious patients with rifampicin in various combinations and in various models].
    Górecki R; Stanek S
    Gruzlica; 1974 May; 42(5):411-6. PubMed ID: 4464229
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.